412 related articles for article (PubMed ID: 2108630)
1. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
Gouin I; Horellou MH; Conard J; Samama M
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
[TBL] [Abstract][Full Text] [Related]
2. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
3. [Quality control of ISI/INR system in oral anticoagulant therapy].
Kazama M
Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
[TBL] [Abstract][Full Text] [Related]
4. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
5. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing.
Ts'ao C; Swedlund J; Neofotistos D
Arch Pathol Lab Med; 1994 Dec; 118(12):1183-7. PubMed ID: 7979911
[TBL] [Abstract][Full Text] [Related]
6. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
[TBL] [Abstract][Full Text] [Related]
7. [Control of the treatment with oral anticoagulants and prothrombin time].
Marzouka E
Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
[TBL] [Abstract][Full Text] [Related]
8. [Control of oral anticoagulation. Current concepts].
Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
[TBL] [Abstract][Full Text] [Related]
9. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
Horsti J
Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
[TBL] [Abstract][Full Text] [Related]
10. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
11. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
12. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
Loeliger EA; van den Besselaar AM; Lewis SM
Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
[TBL] [Abstract][Full Text] [Related]
13. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
Kitchen S; Preston FE
Semin Thromb Hemost; 1999; 25(1):17-25. PubMed ID: 10327216
[TBL] [Abstract][Full Text] [Related]
14. [The international normalization ratio in the monitoring of oral anticoagulant therapy].
Sansores-García L; Majluf-Cruz AS; Vargas-Vorácková F; Labardini-Méndez J
Rev Invest Clin; 1993; 45(5):463-7. PubMed ID: 8134728
[TBL] [Abstract][Full Text] [Related]
15. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.
Sermon AM; Smith JM; Maclean R; Kitchen S
Thromb Haemost; 2010 Apr; 103(4):757-65. PubMed ID: 20174759
[TBL] [Abstract][Full Text] [Related]
16. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
van den Besselaar AM
J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
[TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
18. [Obtaining a reference pattern of rabbit brain thromboplastin].
Martínez Placencia BM; Lanzetti Theiler MC; Córdova Caballero MS
Rev Invest Clin; 1989; 41(3):247-52. PubMed ID: 2813999
[TBL] [Abstract][Full Text] [Related]
19. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
Guglielmone HA; Vides MA
Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
Robert A; Chazouillères O
Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]